BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017

Mar 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-02-28

Reporting Person: SPIEGELMAN DANIEL K (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-28	Common Stock	M	30000	$63.1	Acquired	60347	Direct
2017-02-28	Common Stock	S	30000	$94	Disposed	30347	Direct
2017-03-01	Common Stock	S	5000	$94.5	Disposed	25347	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-28	Stock Option (right to buy) Common Stock	$63.10	M	30000	Disposed	2024-06-03	Common Stock (30000)	Direct

Footnotes

F1: Transaction made pursuant to a 10b5-1 trading plan executed on November 16, 2016.

F2: All shares were sold at the same price.

F3: Original option grant vests 6/48ths on December 4, 2014, and 1/48th on the 4th day of every month thereafter.

F4: Reflects the number of stock options that remain outstanding from this specific stock grant following the reported transaction.